Partners HealthCare Personalized Medicine (PPM) is a center within the Partners HealthCare system (founded by Massachusetts General Hospital and Brigham andWomen’s Hospital) whose mission is to utilize genetics and genomics to improve the care of patients in a cost effective manner. PPM consists of five interconnected components: (1) Laboratory for Molecular Medicine (LMM), a CLIA laboratory performing genetic testing for patients world-wide, (2) Translational Genomics Core (TGC), a core laboratory providing genomic platforms for Partners investigators, (3) Partners Biobank, a biobank of samples (DNA, plasma and serum) for 50,000 Consented Partners patients, (4) Biobank Portal, an IT infrastructure and viewer to bring together genotypes, samples, phenotypes (validated diagnoses, radiology, and clinical chemistry) from the electronic medical record to Partners investigators. These components are united by (5) a common IT system that brings researchers, clinicians, and patients together for optimal research and patient care.
Weiss, S. T., & Shin, M. S. (2016). Infrastructure for personalized medicine at partners healthcare. Journal of Personalized Medicine, 6(1). https://doi.org/10.3390/jpm6010013